These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 28543987)

  • 1. Modified GAP index for prediction of acute exacerbation of idiopathic pulmonary fibrosis in non-small cell lung cancer.
    Kobayashi H; Omori S; Nakashima K; Wakuda K; Ono A; Kenmotsu H; Naito T; Murakami H; Endo M; Takahashi T
    Respirology; 2017 Oct; 22(7):1379-1385. PubMed ID: 28543987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined pulmonary fibrosis and emphysema and idiopathic pulmonary fibrosis in non-small cell lung cancer: impact on survival and acute exacerbation.
    Moon SW; Park MS; Kim YS; Jang J; Lee JH; Lee CT; Chung JH; Shim HS; Lee KW; Kim SS; Lee SH; Yoon HI
    BMC Pulm Med; 2019 Oct; 19(1):177. PubMed ID: 31615505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ILD-NSCLC-GAP index scoring and staging system for patients with non-small cell lung cancer and interstitial lung disease.
    Kobayashi H; Naito T; Omae K; Omori S; Nakashima K; Wakuda K; Ono A; Kenmotsu H; Murakami H; Endo M; Takahashi T
    Lung Cancer; 2018 Jul; 121():48-53. PubMed ID: 29858026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for acute exacerbation of idiopathic pulmonary fibrosis: A systematic review and meta-analysis.
    Qiu M; Chen Y; Ye Q
    Clin Respir J; 2018 Mar; 12(3):1084-1092. PubMed ID: 28332341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute exacerbation of unclassifiable idiopathic interstitial pneumonia: comparison with idiopathic pulmonary fibrosis.
    Enomoto N; Naoi H; Aono Y; Katsumata M; Horiike Y; Yasui H; Karayama M; Hozumi H; Suzuki Y; Furuhashi K; Fujisawa T; Inui N; Nakamura Y; Suda T
    Ther Adv Respir Dis; 2020; 14():1753466620935774. PubMed ID: 32600180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of acute exacerbation in biopsy-proven idiopathic pulmonary fibrosis.
    Kishaba T; Hozumi H; Fujisawa T; Nei Y; Enomoto N; Sugiura H; Kitani M; Suda T
    Respir Investig; 2020 May; 58(3):177-184. PubMed ID: 32205147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Acute Exacerbation of Idiopathic Pulmonary Fibrosis on Lung Transplantation Outcome.
    Dotan Y; Vaidy A; Shapiro WB; Zhao H; Dass C; Toyoda Y; Marchetti N; Shenoy K; Cordova FC; Criner GJ; Mamary AJ
    Chest; 2018 Oct; 154(4):818-826. PubMed ID: 29966665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Newly defined acute exacerbation of idiopathic pulmonary fibrosis with surgically-proven usual interstitial pneumonia: risk factors and outcome.
    Okuda R; Hagiwara E; Katano T; Ikeda S; Sekine A; Kitamura H; Baba T; Okudela K; Ohashi K; Ogura T
    Sarcoidosis Vasc Diffuse Lung Dis; 2019; 36(1):39-46. PubMed ID: 32476935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EMPIRE Registry, Czech Part: Impact of demographics, pulmonary function and HRCT on survival and clinical course in idiopathic pulmonary fibrosis.
    Doubková M; Švancara J; Svoboda M; Šterclová M; Bartoš V; Plačková M; Lacina L; Žurková M; Binková I; Bittenglová R; Lošťáková V; Merta Z; Šišková L; Tyl R; Lisá P; Šuldová H; Petřík F; Pšikalová J; Řihák V; Snížek T; Reiterer P; Homolka J; Musilová P; Lněnička J; Palúch P; Hrdina R; Králová R; Hortvíková H; Strenková J; Vašáková M
    Clin Respir J; 2018 Apr; 12(4):1526-1535. PubMed ID: 28862397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of angiopoietin-1 and -2 on clinical course of idiopathic pulmonary fibrosis.
    Uehara M; Enomoto N; Mikamo M; Oyama Y; Kono M; Fujisawa T; Inui N; Nakamura Y; Suda T
    Respir Med; 2016 May; 114():18-26. PubMed ID: 27109807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival after repeated surgery for lung cancer with idiopathic pulmonary fibrosis: a retrospective study.
    Sato S; Shimizu Y; Goto T; Kitahara A; Koike T; Ishikawa H; Watanabe T; Tsuchida M
    BMC Pulm Med; 2018 Aug; 18(1):134. PubMed ID: 30097033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Radiotherapy of Lung Tumours in Idiopathic Pulmonary Fibrosis].
    Kolek V; Vašáková M; Šterclová M; Cwiertka K; Vrána D; Kudláček A; Skřičková J; Pešek M; Petera J
    Klin Onkol; 2017; 30(4):303-306. PubMed ID: 28832178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of CT-guided percutaneous microwave ablation for stage I non-small cell lung cancer in patients with comorbid idiopathic pulmonary fibrosis.
    Peng J; Bie Z; Li Y; Guo R; Li X
    Eur Radiol; 2024 Jul; 34(7):4708-4715. PubMed ID: 38114848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multi-dimensional scores to predict mortality in patients with idiopathic pulmonary fibrosis undergoing lung transplantation assessment.
    Fisher JH; Al-Hejaili F; Kandel S; Hirji A; Shapera S; Mura M
    Respir Med; 2017 Apr; 125():65-71. PubMed ID: 28340864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival after surgery for pathologic stage IA non-small cell lung cancer associated with idiopathic pulmonary fibrosis.
    Saito Y; Kawai Y; Takahashi N; Ikeya T; Murai K; Kawabata Y; Hoshi E
    Ann Thorac Surg; 2011 Nov; 92(5):1812-7. PubMed ID: 21944440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of IFN-γ, sCD163, CCL2 and CXCL10 involved in acute exacerbation of idiopathic pulmonary fibrosis.
    Gui X; Qiu X; Tian Y; Xie M; Li H; Gao Y; Zhuang Y; Cao M; Ding H; Ding J; Zhang Y; Cai H
    Int Immunopharmacol; 2019 May; 70():208-215. PubMed ID: 30851700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and effectiveness of pirfenidone combined with carboplatin-based chemotherapy in patients with idiopathic pulmonary fibrosis and non-small cell lung cancer: A retrospective cohort study.
    Yamamoto Y; Yano Y; Kuge T; Okabe F; Ishijima M; Uenami T; Kanazu M; Akazawa Y; Yamaguchi T; Mori M
    Thorac Cancer; 2020 Nov; 11(11):3317-3325. PubMed ID: 32986306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognosis and causes of death of patients with acute exacerbation of fibrosing interstitial lung diseases.
    Salonen J; Purokivi M; Bloigu R; Kaarteenaho R
    BMJ Open Respir Res; 2020 Apr; 7(1):. PubMed ID: 32265195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase II trial evaluating the efficacy and safety of perioperative pirfenidone for prevention of acute exacerbation of idiopathic pulmonary fibrosis in lung cancer patients undergoing pulmonary resection: West Japan Oncology Group 6711 L (PEOPLE Study).
    Iwata T; Yoshino I; Yoshida S; Ikeda N; Tsuboi M; Asato Y; Katakami N; Sakamoto K; Yamashita Y; Okami J; Mitsudomi T; Yamashita M; Yokouchi H; Okubo K; Okada M; Takenoyama M; Chida M; Tomii K; Matsuura M; Azuma A; Iwasawa T; Kuwano K; Sakai S; Hiroshima K; Fukuoka J; Yoshimura K; Tada H; Nakagawa K; Nakanishi Y;
    Respir Res; 2016 Jul; 17(1):90. PubMed ID: 27450274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterogeneity of incidence and outcome of acute exacerbation in idiopathic interstitial pneumonia.
    Arai T; Kagawa T; Sasaki Y; Sugawara R; Sugimoto C; Tachibana K; Kitaichi M; Akira M; Hayashi S; Inoue Y
    Respirology; 2016 Nov; 21(8):1431-1437. PubMed ID: 27460223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.